Related Experiment Videos
Fulminant amebic colitis
H Aristizábal1, J Acevedo, M Botero
1Department of Surgery, University of Antioquia School of Medicine, Medellín, Colombia.
World Journal of Surgery
|March 1, 1991
Summary
Fulminating amebic colitis caused by Entamoeba histolytica is a severe disease with high mortality. Early diagnosis and treatment, including metronidazole and surgery, improved survival rates from 0% to 40%.
Area of Science:
- Infectious Diseases
- Gastroenterology
- Tropical Medicine
Background:
- Amebiasis, caused by Entamoeba histolytica, is endemic in tropical and subtropical regions.
- It can affect various organs, primarily the colon, presenting diverse clinical forms.
- Fulminant amebic colitis is a severe, though infrequent, manifestation associated with high morbidity and mortality.
Purpose of the Study:
- To report on the management and outcomes of adult patients with fulminant amebic colitis.
- To evaluate the impact of early diagnosis, antiamebic treatment, and surgical intervention on survival rates.
Main Methods:
- Retrospective case series of 50 adult patients with fulminant amebic colitis.
- Management included antiamebic agents (metronidazole) and aggressive surgical intervention.
- Data collected from January 1971 to July 1989.
Main Results:
- Global mortality rate was 60% over the study period.
- Prior to 1970, there were no survivors.
- The current survival rate improved to 40% with the implemented management strategies.
Conclusions:
- Fulminant amebic colitis remains a severe condition with significant mortality.
- Early diagnosis, effective antiamebic therapy (metronidazole), and timely surgical intervention are crucial for improving patient survival.
- Continued efforts are needed to further enhance survival rates for this critical illness.